BELL vs. POLX, RUA, MHC, IHC, SUN, IUG, NCYT, SAR, KNB, and ABDX
Should you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Polarean Imaging (POLX), RUA Life Sciences (RUA), MyHealthChecked (MHC), Inspiration Healthcare Group (IHC), Surgical Innovations Group (SUN), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Sareum (SAR), Kanabo Group (KNB), and Abingdon Health (ABDX). These companies are all part of the "medical" sector.
Polarean Imaging (LON:POLX) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.
In the previous week, Belluscura's average media sentiment score of 0.00 equaled Polarean Imaging'saverage media sentiment score.
Polarean Imaging's return on equity of -40.83% beat Belluscura's return on equity.
Polarean Imaging received 23 more outperform votes than Belluscura when rated by MarketBeat users.
23.4% of Polarean Imaging shares are held by institutional investors. Comparatively, 16.0% of Belluscura shares are held by institutional investors. 28.0% of Polarean Imaging shares are held by company insiders. Comparatively, 45.9% of Belluscura shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Polarean Imaging has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Comparatively, Belluscura has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500.
Belluscura has higher revenue and earnings than Polarean Imaging. Belluscura is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.
Summary
Belluscura beats Polarean Imaging on 7 of the 11 factors compared between the two stocks.
Get Belluscura News Delivered to You Automatically
Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Belluscura Competitors List
Related Companies and Tools
